Exploring the dichotomy of the mesenchymal stem cell secretome: Implications for tumor modulation via cell-signaling

Mohammad Rasouli1, Mana Alavi1, Alberto D'Angelo2

  • 1Department of Biology, Faculty of Science, University of Guilan, Rasht, Iran.

PubMed

Insights

Mesenchymal stem cells (MSCs) offer a novel anticancer platform due to their unique properties. Their secretome can either promote or inhibit tumor growth, acting as a double-edged sword in cancer therapy.

Area of Science:

  • Oncology
  • Stem Cell Biology
  • Biotechnology

Background:

  • Current cancer therapies face challenges with side effects and drug resistance.
  • Stem cell-based treatments are emerging as promising anticancer platforms.
  • Mesenchymal stem cells (MSCs) possess unique biological properties, including self-renewal and low immunogenicity.

Purpose of the Study:

  • To review the role of mesenchymal stem cell (MSC) secretome in cancer.
  • To explore the dual role of MSC secretome in tumor regulation.
  • To highlight MSCs as a potential anticancer therapeutic strategy.

Main Methods:

  • Review of current literature on MSC secretome and cancer.
  • Analysis of bioactive factors secreted by MSCs.
  • Examination of signaling pathways influenced by MSC secretome.

Main Results:

  • MSC secretome contains trophic factors like cytokines, chemokines, and microRNAs.
  • These factors can exhibit context-dependent effects on tumor growth.
  • MSCs can act as a double-edged sword, either suppressing or promoting tumors.

Conclusions:

  • The MSC secretome presents a complex but potent therapeutic avenue for cancer treatment.
  • Understanding the tumor microenvironment is crucial for harnessing MSCs' anticancer potential.
  • Further research into MSC secretome modulation is warranted for effective cancer therapy.

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Stem Cell Niche01:26

Stem Cell Niche

The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
5.0K